Wantstats
Company ProfilePremium

Biocrates Life Sciences AG

Company Profile Analysis

Book DemoRegister Your Interest
ESOMAR 23 Corporate BadgeISO Certifications Badge
Biocrates Life Sciences AG - Healthcare showcase

Year Founded & Workforce

2003

50 Employees

Industry

Healthcare

Services

Metabolic Phenotyping ServicesResearch ProductsCO2 Absorbents
B

Biocrates Life Sciences AG Employee Contacts

8 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Biocrates Life Sciences AG Overview

Company Headquarters: Austria

Founded: 2003

Workforce: ~50

Company Working: Biocrates Life Sciences AG (Biocrates) is a global solution provider for metabolomics services. In addition to metabolomics services, the company is engaged in developing clinical biomarker assays and quality control assays to advance clinical study outcomes. The product offered by the company such as Biocrates biomarkers focuses on diagnostic of diabetes, early diagnosis of pancreatic cancer (PDAC), congestive heart failure (CHF), kidney disease, sepsis, stroke, and various types of cancer such as ovarian and breast cancer.

Strategy

Biocrates focuses on collaborating with pharmaceutical, nutrition, and biotech companies, and also with academic centers and universities to further develop and market metabolomics biomarker products. Additionally, the company is also aiming at expanding its product portfolio by mergers & acquisition with emerging companies

Company Snapshot

50

Employees

2003

Founded

Austria

Headquarters

SWOT Analysis

Strengths

  • Strong product portfolio
  • Well-developed distribution network

Weaknesses

  • Limited workforce

Opportunities

  • Increasing prevalence of chronic diseases
  • Rising demand for innovative diagnostic kits

Threats

  • Stringent government regulations
  • Fluctuating exchange rates
  • Increasing competition

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
January 2018AcquisitionBiocrates acquired Metanomics Health GmbH a Germany-based company. Metanomics Health GmbH is a specialist in developing metabolomics biomarker and healthcare services. This acquisition provided the metabolomics product portfolio in the industry.
November 2018LaunchBiocrates launched MxP Quant 500, which is a quantitative analytical kit used to measure metabolites produced by intestinal bacteria.
June 2017LaunchBiocrates and Thermo Fisher Scientific launched AbsoluteIDQ p400 HR kit a ready-to-use metabolic phenotyping kit. The launch of AbsoluteIDQ p400 HR extended the highly regarded metabolomics kit portfolio of the respective firms.

Product Offering

  • Biocrates Life Sciences AG
    • Metabolic Phenotyping Services
    • Research Products
    • CO2 Absorbents

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →